The ECRI Institute today issued guidance on reprocessing reusable duodenoscopes to reduce the risk of Carbapenem-Resistant Enterobacteriaceae infections. “As this hazard has gained national attention, an ECRI Institute team of physicians, clinical specialists, infection control practitioners, biomedical engineers and others have intensively researched and reviewed the best approaches to address this problem,” the report states, noting that “no single solution will work for all health care organizations.” FDA last month issued safety recommendations to prevent possible microbial infections from reprocessed reusable duodenoscopes – flexible, lighted tubes that are threaded through the mouth into the small intestine to drain fluids from blocked pancreatic and biliary ducts. According to the advisory, the agency has received in the past two years 75 reports involving possible microbial transmission from reprocessed duodenoscopes, including multidrug-resistant bacterial infections. 

Related News Articles

Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Sept. 30 to review their 2016 quality data before it is publicly reported on the…
Headline
The Institute for Safe Medication Practices yesterday released a tool to help hospitals and outpatient facilities evaluate their safety practices for “…
Headline
The Centers for Medicare & Medicaid Services seeks comments through Nov. 20 on a “new direction” for its Innovation Center that will approach…